CATX

Latest SEC Filings & News for CATX

2 most recent filings and news items mentioning CATX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/CATX/news?limit=20"

Pull CATX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJun 1, 2026Positive

Perspective Therapeutics advances radiopharmaceutical pipeline with lead 212Pb programs.

Perspective Therapeutics presented clinical data on three wholly-owned radiopharmaceutical candidates targeting oncology indications including neuroendocrine tumors, melanoma, and solid tumors. The company's next-generation alpha-emitter platform and regional manufacturing strate

View filing at SEC.gov →

OtherMay 21, 2026Positive

Perspective Therapeutics to present clinical data from three programs at 2026 ASCO

Perspective Therapeutics announced it will present updates on three radiopharmaceutical programs at the 2026 ASCO Annual Meeting, including positive interim data from its [212Pb]VMT01 melanoma study showing 29% response rate and well-tolerated safety profile across all programs.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.